Chronic kidney disease and end-stage renal disease management company Monogram Health has closed a $160 million Series B funding round led by TPG Capital.
Existing investors Frist Cressey Ventures, Norwest Venture Partners and Humana Inc. also participated in the raise.
Along with their investment, TPG Capital co-managing partner Todd Sisitsky is joining Monogram’s board of directors.
WHAT IT...
